MedTrace Logo

Patient-reported Outcomes in Bladder Cancer

NCT03584659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2022-10-25

No results posted yet for this study

Summary

Electronic reporting of patient-reported outcomes with alert algorithm will be tested in a randomized trial in bladder cancer patients undergoing chemo- or immunotherapy. The clinical endpoints will be:

* Quality of life
* Completion of treatment
* Hospital admission
* Dose reductions
* Survival

Conditions

Interventions

DEVICE

Electronic patient-reported outcomes

Weekly reporting of patient-reported outcomes for closer contact between patient and clinic between treatment cycles.

Sponsors & Collaborators

  • Herlev Hospital

    collaborator OTHER

  • Danish Cancer Society

    collaborator OTHER

  • Aalborg University Hospital

    collaborator OTHER

  • Odense University Hospital

    collaborator OTHER

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Gry Assam Taarnhøj, MD · Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-21
Primary Completion
2021-09-30
Completion
2022-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03584659 on ClinicalTrials.gov